Phase 2, Randomized, Double-blind, A Placebo-controlled, Dose Ranging Study to Assess the Efficacy and Safety of Rocatinlimab in Adult Subjects With Moderate-to-severe Uncontrolled Asthma

Principal Investigator

Dr Timothy Hinks

Contact us

Email: severeasthmaclinic@ouh.nhs.uk

Phone: 01865227242

IRAS number

1009571